Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Oct. 31, 2023		Oct. 31, 2022
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss, including amounts attributable to noncontrolling interest	$ (390,462)		$ (138,575)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Stock-based compensation expense	120,032		88,926
Charitable donation of common stock	8,025		0
Amortization of intangible assets	1,646		1,767
Depreciation expense	3,329		2,198
Amortization of deferred contract acquisition costs	31,066		32,693
Gain from deconsolidation of Meltano Inc.	0		(17,798)
Loss from equity method investment	3,048		2,247
Net amortization of premiums or discounts on short-term investments	(14,361)		(3,346)
Unrealized foreign exchange loss (gain), net	252		(4,081)
Other non-cash expense, net	317		439
Changes in assets and liabilities:
Accounts receivable	(5,291)		(22,163)
Prepaid expenses and other current assets	(8,183)		(5,320)
Deferred contract acquisition costs	(31,760)		(33,145)
Other non-current assets	(1,174)		2,050
Accounts payable	(224)		1,393
Accrued expenses and other current liabilities	245,857		3,249
Accrued compensation and benefits	2,842		(15,150)
Deferred revenue	29,158		40,200
Other non-current liabilities	16,070		(1,272)
Net cash provided by (used in) operating activities	10,187		(65,688)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of short-term investments	(573,676)		(631,951)
Proceeds from maturities of short-term investments	526,979		122,701
Purchases of property and equipment	(1,269)		(5,018)
Deconsolidation of Meltano Inc.	0		(9,620)
Escrow payment related to business combination, after acquisition date	(2,500)		0
Net cash used in investing activities	(50,466)		(523,888)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from the issuance of common stock upon exercise of stock options, including early exercises, net of repurchases	22,492		17,454
Issuance of common stock under employee stock purchase plan	7,751		9,554
Contributions received from noncontrolling interests, net of issuance costs	0		61,726
Partial settlement of acquisition related contingent cash consideration	0		(3,137)
Net cash provided by financing activities	30,243		85,597
Impact of foreign exchange on cash and cash equivalents	(2,557)		(8,524)
Net decrease in cash and cash equivalents	(12,593)		(512,503)
Cash, cash equivalents, and restricted cash at beginning of period	297,902		887,172
Cash, cash equivalents, and restricted cash at end of period	285,309		374,669
Supplemental disclosure of cash flow information:
Cash paid for income taxes	6,015		527
Supplemental disclosure of non-cash investing and financing activities:
Vesting of early exercised stock options	1,030		4,106
Unpaid property and equipment in accrued expenses	68		0
Reconciliation of cash, cash equivalents and restricted cash within the condensed consolidated balance sheets to the amounts shown in the condensed consolidated statements of cash flows above:
Cash and cash equivalents	285,309	[1]	372,169
Restricted cash, included in prepaid expenses and other current assets	0		2,500
Total cash, cash equivalents and restricted cash	$ 285,309		$ 374,669

[1] (1) As of October 31, 2023 and January 31, 2023, the condensed consolidated balance sheet includes assets of the consolidated variable interest entity, GitLab Information Technology (Hubei) Co., LTD (“JiHu”), of $48.6 million and $62.8 million, respectively, and liabilities of $5.9 million and $8.9 million, respectively. The assets of JiHu can be used only to settle obligations of JiHu and creditors of JiHu do not have recourse against the general credit of the Company. Refer to “Note 12. Joint Venture and Equity Method Investment” for further discussion.